EDGAR Filing Documents for 0000950133-04-002131

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0000950133-04-002131

Filing Date

2004-05-20

Accepted

2004-05-20 16:38:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	w97645sv3.htm	S-3	281924
2	EXHIBIT 4.04	w97645exv4w04.htm	EX-4.04	227027
3	EXHIBIT 4.05	w97645exv4w05.htm	EX-4.05	228213
4	EXHIBIT 4.08	w97645exv4w08.htm	EX-4.08	100502
5	EXHIBIT 4.09	w97645exv4w09.htm	EX-4.09	112239
6	EXHIBIT 4.10	w97645exv4w10.htm	EX-4.10	112524
7	EXHIBIT 5.01	w97645exv5w01.htm	EX-5.01	19596
8	EXHIBIT 12.01	w97645exv12w01.htm	EX-12.01	15164
9	EXHIBIT 23.01	w97645exv23w01.htm	EX-23.01	1519
10	EXHIBIT 23.02	w97645exv23w02.htm	EX-23.02	1204
	Complete submission text file	0000950133-04-002131.txt		1102312

Mailing Address

Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300

GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)